Home » Authors » Cormac Sheridan

Articles by Cormac Sheridan

Bavarian Nordic Lands $36M for Imvamune Production

Dec. 8, 2010

By Cormac Sheridan

Basilea to Receive $130M Arbitration Award from J&J

Dec. 1, 2010

By Cormac Sheridan

Covagen Raises $6M to Fund Fynomer Scaffolds Technology

Dec. 1, 2010

By Cormac Sheridan

Basilea to Receive $130M Arbitration Award from J&J

Nov. 30, 2010

By Cormac Sheridan

Zealand Lists on Copenhagen Exchange in Scaled-Back IPO

Nov. 24, 2010

By Cormac Sheridan

Local Investors Help Clavis with $26M Private Placement

Nov. 24, 2010

By Cormac Sheridan

Paion Stock Rises Briefly on Phase IIb Remimazolam Data

Nov. 24, 2010

By Cormac Sheridan

Zealand Lists on Copenhagen Exchange in Scaled-Back IPO

Nov. 24, 2010

By Cormac Sheridan

Ireland Retains Commitment to Low Corporation Tax

Nov. 17, 2010

By Cormac Sheridan

Clavis, Clovis Extend CP-4126 Pact into Asia

Nov. 17, 2010

By Cormac Sheridan

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 18, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
For clonal hematopoiesis, epigenetics can be in driver’s seat
BioWorld Science
Clonal hematopoiesis (CH), where few blood stem cells produce a significant fraction of mature blood cells that are genetically identical, is partly an inevitable...
Elixiron’s enrupatinib shows upbeat interim phase II AD results
BioWorld
Elixiron Immunotherapeutics Inc. announced positive interim open-label phase II Alzheimer’s disease (AD) study findings of enrupatinib, an oral brain-penetrant...
Gene replacement rescues autism-related phenotypes in mice
BioWorld Science
Autism spectrum disorder (ASD), developmental epileptic encephalopathies and other neurodevelopmental disorders are driven by the disruption of genes regulating...